Drug Treatments for Patients with Dysthymia

Kripke, Clarissa
October 2004
American Family Physician;10/1/2004, Vol. 70 Issue 7, p1269
Academic Journal
Presents information on drug treatments that are effective for dysthymia. Comparison between the efficacy of anti-depressants and placebo; Information on the side effects of tricyclic antidepressants and selective serotonin reuptake inhibitors.


Related Articles

  • Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Peet, Malcolm; Peet, M // British Journal of Psychiatry;Apr94, Vol. 164, p549 

    The rate of treatment-emergent switch into mania has been calculated from all available clinical trial data on the selective serotonin re-uptake inhibitors (SSRIs) fluoxetine, fluvoxamine, paroxetine, and sertraline, relative to comparative groups treated with tricyclic antidepressants (TCAs) or...

  • Mirtazapine. A pharmacoeconomic review of its use in depression. Holm, K.J.; Jarvis, B.; Foster, R.H. // PharmacoEconomics;2000, Vol. 17 Issue 5, p515 

    Unlabelled: Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). The antidepressant efficacy of mirtazapine has been established in randomised, double-blind comparative studies. Mirtazapine has generally shown similar efficacy to other antidepressants....

  • ACP treatment guideline for antidepressants.  // Infectious Disease Alert;Jan2009 Pharmacology Watch, p2 

    The article presents the practice guideline issued by the American College of Physicians (ACP) in January 2009 for the use of antidepressants for treatment of depressive disorder. The guideline covers the use of second-generation antidepressants like fluoxetine (Prozac), duloxetine (Cymbalta)...

  • Antidepressants and anxiolytics. Vallone, Doris C.; Chase, Sandra; Cerrato, Paul L. // RN;Jul97, Vol. 60 Issue 7, p27 

    Focuses on how antidepressants work by blocking a process called reuptake. How serotonin elevates moods and helps regulate sleeping patterns; What patients can expect when taking tracyclics; Increasing popularity of selective serotonin reuptake inhibitors.

  • Tricyclics, SSRIs don't harm the fetus.  // Modern Medicine;Mar97, Vol. 65 Issue 3, p5 

    Focuses on the results of a Canadian study indicating that women who do not require drug therapy for depression during pregnancy can take a tricyclic antidepressant or a selective serotonin reuptake inhibitor (SSRI) without worrying about harming their child. Absence of language, behavior or...

  • Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Mourilhe, P.; Stokes, P.E. // Drug Safety;Jan1998, Vol. 18 Issue 1, p57 

    Depression is a common, life-disrupting, potentially lethal illness that can affect both sexes and all ages. Its peak onset is in the early adult years. It is more common than hypertension in primary care practice. Recent studies show that fewer than 1 in 20 depressed patients are correctly...

  • Clinical Q&A. Cicero, Lorraine A.; Pareddy, Satyapal R. // Drug Topics;5/5/97, Vol. 141 Issue 9, p49 

    Answers a query on whether selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCA) can be used safely in the treatment of depression. Causes of symptoms of depression; Two perspectives in the concomitant use of SSRIs and TCAs.

  • Antidepressant Treatment Strategies in the Perinatal Period with a Focus on SSRI use. SAATCİOĞLU, Ömer; Buket TOMRUK, Nesrin // Archives of Neuropsychiatry / Noropsikiatri Arsivi;Mar2013, Vol. 50 Issue 1, p93 

    A letter to the editor is presented which is concerned with antidepressant treatment strategies in the perinatal period with a focus on selective serotonin reuptake inhibitors.

  • Tricyclic Antidepressants vs. SSRIs in Depressed Patients. Walling, Anne D. // American Family Physician;1/1/2004, Vol. 69 Issue 1, p195 

    Compares the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRI) and tricyclic antidepressants in treating depressed patients. Review of the evidence for efficacy and tolerability of SSRI and tricyclic antidepressants; Studies that met the criteria for inclusion in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics